Metabasis Therapeutics (MBRX) Sees Upside
Metabasis Therapeutics Inc. (Nasdaq: MBRX) is 50% higher AM on volume that is more than 5x normal already. We have not seen any news to explain the spike.
A call to the company has not been answered.
A call to the company has not been answered.
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- When Will Rosetta Genomics (ROSG) Crash From its 1346% Gain?
- SodaStream (SODA) Shares Volatile as Exec Says Co. Received Approval to Sell Products in Brazil
Create E-mail Alert Related Categories
Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
